Cross-reactivity of a pathogenic autoantibody to a tumor antigen in GABA


Journal

Proceedings of the National Academy of Sciences of the United States of America
ISSN: 1091-6490
Titre abrégé: Proc Natl Acad Sci U S A
Pays: United States
ID NLM: 7505876

Informations de publication

Date de publication:
02 03 2021
Historique:
entrez: 23 2 2021
pubmed: 24 2 2021
medline: 10 8 2021
Statut: ppublish

Résumé

Encephalitis associated with antibodies against the neuronal gamma-aminobutyric acid A receptor (GABA

Identifiants

pubmed: 33619082
pii: 1916337118
doi: 10.1073/pnas.1916337118
pmc: PMC7936355
pii:
doi:

Substances chimiques

Antigens, Neoplasm 0
Autoantibodies 0
Autoantigens 0
Biomarkers 0
Receptors, GABA-A 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Déclaration de conflit d'intérêts

The authors declare no competing interest.

Références

Eur J Neurol. 2011 Jan;18(1):19-e3
pubmed: 20880069
Neuropsychiatr Dis Treat. 2016 Oct 27;12:2775-2787
pubmed: 27822050
Sci Rep. 2018 Jul 5;8(1):10191
pubmed: 29976963
Oncotarget. 2017 May 30;8(22):35984-36000
pubmed: 28415593
Ann Clin Transl Neurol. 2020 Feb;7(2):239-244
pubmed: 31943946
Oncotarget. 2016 Mar 22;7(12):13688-705
pubmed: 26883198
Science. 1991 Sep 20;253(5026):1420-3
pubmed: 1654594
Neurol Neuroimmunol Neuroinflamm. 2019 Apr 04;6(3):e552
pubmed: 31119187
Lancet Neurol. 2014 Mar;13(3):276-86
pubmed: 24462240
Curr Opin Neurol. 2020 Jun;33(3):372-380
pubmed: 32374573
PLoS One. 2016 Feb 10;11(2):e0147739
pubmed: 26863016
Lancet Neurol. 2008 Apr;7(4):327-40
pubmed: 18339348
Nat Med. 2008 Jun;14(6):688-93
pubmed: 18488038
Neurol Neuroimmunol Neuroinflamm. 2019 Sep 25;6(6):
pubmed: 31554672
Neurology. 2015 Mar 24;84(12):1233-41
pubmed: 25636713
Lancet Neurol. 2011 Aug;10(8):759-72
pubmed: 21777830
Neurol Neuroimmunol Neuroinflamm. 2015 Feb 12;2(2):e73
pubmed: 25738169
J Neurosci. 2014 Jun 11;34(24):8151-63
pubmed: 24920620
Autoimmun Rev. 2014 Mar;13(3):299-312
pubmed: 24225076
Neurology. 2017 Mar 14;88(11):1012-1020
pubmed: 28202703
Br J Pharmacol. 2015 Jun;172(12):3126-40
pubmed: 25684311
Cell Mol Life Sci. 2018 Jun;75(11):1959-1971
pubmed: 29428964
J Neurosci. 2015 May 13;35(19):7317-25
pubmed: 25972162
J Neurol. 2013 May;260(5):1215-33
pubmed: 22983427
Neurol Neuroimmunol Neuroinflamm. 2019 Apr 04;6(3):e554
pubmed: 31044145
J Biol Chem. 2013 Jul 19;288(29):21458-21472
pubmed: 23744069
N Engl J Med. 2018 Mar 1;378(9):840-851
pubmed: 29490181
Jpn J Cancer Res. 2002 Jun;93(6):636-43
pubmed: 12079511
Nat Rev Cancer. 2013 Feb;13(2):111-22
pubmed: 23303138
BMC Genomics. 2006 Apr 27;7:96
pubmed: 16643655
Proc Natl Acad Sci U S A. 2016 Jul 12;113(28):7864-9
pubmed: 27325759

Auteurs

Simone M Brändle (SM)

Institute of Clinical Neuroimmunology, Biomedical Center and Hospital of the Ludwig-Maximilians-Universität München, D-82152 Martinsried, Germany.

Manuela Cerina (M)

Department of Neurology, Institute of Translational Neurology, University of Münster, D-48149 Münster, Germany.

Susanne Weber (S)

Institute of Clinical Neuroimmunology, Biomedical Center and Hospital of the Ludwig-Maximilians-Universität München, D-82152 Martinsried, Germany.

Kathrin Held (K)

Division of Infectious Diseases and Tropical Medicine, University Hospital, Ludwig Maximilian University of Munich, D-80539 Munich, Germany.
German Centre for Infection Research (DZIF), D-80937 Munich, Germany.

Amélie F Menke (AF)

Department of Neurology, Institute of Translational Neurology, University of Münster, D-48149 Münster, Germany.

Carmen Alcalá (C)

Neuroimmunology Unit, Hospital Universitari i Politècnic la Fe, 46026 Valencia, Spain.

David Gebert (D)

Institute of Clinical Neuroimmunology, Biomedical Center and Hospital of the Ludwig-Maximilians-Universität München, D-82152 Martinsried, Germany.

Alexander M Herrmann (AM)

Department of Neurology, Institute of Translational Neurology, University of Münster, D-48149 Münster, Germany.

Hannah Pellkofer (H)

Institute of Clinical Neuroimmunology, Biomedical Center and Hospital of the Ludwig-Maximilians-Universität München, D-82152 Martinsried, Germany.

Lisa Ann Gerdes (LA)

Institute of Clinical Neuroimmunology, Biomedical Center and Hospital of the Ludwig-Maximilians-Universität München, D-82152 Martinsried, Germany.

Stefan Bittner (S)

Department of Neurology, University of Mainz, D-55131 Mainz, Germany.

Frank Leypoldt (F)

Institute of Clinical Chemistry, University of Kiel, D-24105 Kiel, Germany.
Department of Neurology, University of Kiel, D-24105 Kiel, Germany.

Bianca Teegen (B)

Clinical-Immunological Laboratory Prof. Dr. Stöcker, D-23560 Lübeck, Germany.

Lars Komorowski (L)

Institute for Experimental Immunology, Euroimmun AG, D-23560 Lübeck, Germany.

Tania Kümpfel (T)

Institute of Clinical Neuroimmunology, Biomedical Center and Hospital of the Ludwig-Maximilians-Universität München, D-82152 Martinsried, Germany.

Reinhard Hohlfeld (R)

Institute of Clinical Neuroimmunology, Biomedical Center and Hospital of the Ludwig-Maximilians-Universität München, D-82152 Martinsried, Germany.
Munich Cluster for Systems Neurology (SyNergy), Ludwig-Maximilians-Universität München, D-81377 München, Germany.

Sven G Meuth (SG)

Department of Neurology, Heinrich-Heine-University of Düsseldorf, D-40225 Düsseldorf, Germany.

Bonaventura Casanova (B)

Neuroimmunology Unit, Hospital Universitari i Politècnic la Fe, 46026 Valencia, Spain.

Nico Melzer (N)

Department of Neurology, Institute of Translational Neurology, University of Münster, D-48149 Münster, Germany.

Eduardo Beltrán (E)

Institute of Clinical Neuroimmunology, Biomedical Center and Hospital of the Ludwig-Maximilians-Universität München, D-82152 Martinsried, Germany.

Klaus Dornmair (K)

Institute of Clinical Neuroimmunology, Biomedical Center and Hospital of the Ludwig-Maximilians-Universität München, D-82152 Martinsried, Germany; Klaus.Dornmair@med.uni-muenchen.de.
Munich Cluster for Systems Neurology (SyNergy), Ludwig-Maximilians-Universität München, D-81377 München, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH